癌症进展和治疗中的微生物群机制
Xing Zhang1, Kyong Tkhe Fam1, Tingting Dai1
1Department of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA.
Cell chemical biology
|May 7, 2025
概括
肠道微生物群影响癌症的进展和治疗反应. 了解它的化学机制为开发改进的癌症诊断和治疗提供了新的途径.
科学领域:
- 微生物组研究的研究.
- 癌症生物学 癌症生物学
- 化学生物学是化学生物学.
背景情况:
- 微生物群的组成与癌症进展和治疗反应相关.
- 这突显了改善患者治疗结果的潜力.
- 了解这些相互作用的化学基础至关重要.
研究的目的:
- 审查了解癌症中微生物群的化学机制的挑战和进展.
- 讨论微生物群在调节癌症和免疫治疗中的作用.
- 探索研究微生物群酶和代谢物的方法.
主要方法:
- 关于化学机制的文献评论
- 分析微生物群在癌症进展中的作用.
- 讨论免疫疗法调制的讨论.
- 对酶和代谢物调查方法的概述.
主要成果:
- 微生物群物种,途径和分子对癌症产生影响.
- 微生物群影响癌症和免疫疗法的有效性.
- 描述了微生物群酶和代谢物的研究方法.
结论:
- 阐明微生物群机制提供了新的诊断和治疗机会.
- 需要创新的化学遗传方法来确定未知的机制.
- 进一步的研究可以提高癌症患者的治疗结果.
相关概念视频
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K


